Boston Scientific (NYSE: BSX) said in an SEC filing that it has entered into a handful of revolving credit facilities.

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.

Boston Scientific (NYSE:BSX) announced today that it promoted Catherine Jennings to become its new president of Vascular ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor..

On Wednesday, Boston Scientific experienced a loss of nearly one-fifth of its market capitalization in a single trading ...

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...

NEW YORK CITY, NY / ACCESS Newswire / February 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX ...

Cathy Smith and Christophe Weber joined Boston Scientific’s board on Wednesday, according to a Monday press release from the ...

Boston Scientific has plans to acquire medtech company Nalu Medical, which specializes in developing and commercializing minimally invasive chronic pain solutions. Boston Scientific has been a Nalu ...

Shares of Boston Scientific Corp. BSX slipped 2.22% to $73.48 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.81% to 6 ...